Collegium Pharmaceutical (COLL) Amortization - Intangibles (2019 - 2026)

Collegium Pharmaceutical's Amortization - Intangibles history runs 8 years deep, the most recent figure standing at $55.5 million for Q1 2026.

• In Q1 2026, Amortization - Intangibles changed 0.0% year-over-year to $55.5 million; the TTM figure through Mar 2026 stood at $221.9 million (up 19.13% YoY), while the FY2025 annual figure was $221.9 million, up 34.23% from the prior year.
• Amortization - Intangibles was $55.5 million for Q1 2026 at Collegium Pharmaceutical, roughly flat from $55.5 million in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $55.5 million in Q1 2025 to a low of $18.9 million in Q1 2022.
• Historically, Amortization - Intangibles has averaged $42.6 million across 5 years, with a median of $37.6 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Amortization - Intangibles jumped 151.74% in 2022, then retreated 18.37% in 2023.
• A 5-year view of Amortization - Intangibles shows it stood at $42.3 million in 2022, then fell by 18.37% to $34.5 million in 2023, then surged by 60.72% to $55.5 million in 2024, then grew by 0.0% to $55.5 million in 2025, then changed by 0.0% to $55.5 million in 2026.
• The last three Amortization - Intangibles figures came in at $55.5 million (Q1 2026), $55.5 million (Q4 2025), and $55.5 million (Q3 2025), per Business Quant data.